1
|
Monagle P, Azzam M, Bercovitz R, Betensky M, Bhat R, Biss T, Branchford B, Brandão LR, Chan AKC, Faustino EVS, Jaffray J, Jones S, Kawtharany H, Kerlin BA, Kucine N, Kumar R, Male C, Pelland-Marcotte MC, Raffini L, Raulji C, Sartain SE, Takemoto CM, Tarango C, van Ommen CH, Velez MC, Vesely SK, Wiernikowski J, Williams S, Wilson HP, Woods G, Zia A, Mustafa RA. American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. Blood Adv 2025; 9:2587-2636. [PMID: 40423983 DOI: 10.1182/bloodadvances.2024015328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2024] [Accepted: 01/14/2025] [Indexed: 05/28/2025] Open
Abstract
BACKGROUND The American Society of Hematology (ASH) guidelines on treatment of pediatric venous thromboembolism (VTE) were published in 2018. In the last 6 years, there has been a 10-fold increase in the number of children involved in VTE treatment trials. OBJECTIVE The ASH Committee on Quality and Guidelines agreed to update the pediatric guidelines in conjunction with the International Society on Thrombosis and Haemostasis (ISTH). These ASH/ISTH evidence-based guidelines are intended to support patients, clinicians, and other health care professionals in the management of pediatric patients with VTE. METHODS ASH/ISTH formed a multidisciplinary guideline panel to minimize potential bias from conflicts of interest. An unconflicted patient representative was not identified. The University of Kansas Health System supported the guideline development process, updating or performing systematic evidence reviews up to 2024. The panel focused specifically on the 2018 questions for which there was the greatest amount of interim data. The panel used the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment. RESULTS The panel agreed on 20 recommendations and also provided implementation guidance on the optimal use of anticoagulants in pediatric patients. Key recommendations of these guidelines include the role of DOACs in the treatment of a variety of pediatric VTEs. CONCLUSIONS Further research is required. Key priorities are understanding the natural history of clinically unsuspected thrombosis across a range of patient subpopulations and obtaining real-world data on the use of DOACs in children.
Collapse
Affiliation(s)
- Paul Monagle
- Departments of Paediatrics and Haematology, The University of Melbourne, Royal Children's Hospital, Murdoch Children's Research Institute, Melbourne, VIC, Australia
| | - Muayad Azzam
- Division of Nephrology, Department of Internal Medicine, Evidence-based Practice and Impact Center, The University of Kansas Health System, Kansas City, KS
| | - Rachel Bercovitz
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
| | - Marisol Betensky
- Division of Hematology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD
- Division of Hematology, Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL
| | - Rukhmi Bhat
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
| | - Tina Biss
- Department of Haematology, The Newcastle Upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom
| | - Brian Branchford
- Department of Hematology, Versiti Medical Science Institute, Wauwatosa, WI
| | - Leonardo R Brandão
- Dalla Lana School of Public Health, University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada
| | - Anthony K C Chan
- Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, ON, Canada
| | - E Vincent S Faustino
- Section of Critical Care, Department of Pediatrics, Yale School of Medicine, New Haven, CT
| | - Julie Jaffray
- Department of Pediatrics, Division of Hematology/Oncology, University of California, San Diego, Rady Children's Hospital, San Diego, CA
| | - Sophie Jones
- Departments of Nursing and Haematology The University of Melbourne, Royal Children's Hospital, Murdoch Children's Research Institute, Melbourne, VIC, Australia
| | - Hassan Kawtharany
- Division of Nephrology, Department of Internal Medicine, Evidence-based Practice and Impact Center, The University of Kansas Health System, Kansas City, KS
| | - Bryce A Kerlin
- Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University, Columbus, OH
| | - Nicole Kucine
- Department of Pediatrics, Weill Cornell Medicine, New York, NY
| | - Riten Kumar
- Department of Pediatrics, Harvard Medical School, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
| | - Christoph Male
- Department of Pediatrics, Medical University of Vienna, Vienna, Austria
| | | | - Leslie Raffini
- Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA
| | - Chittalsinh Raulji
- Department of Pediatrics, University of Nebraska Medical Center, Children's Hospital Nebraska, Omaha, NE
| | - Sarah E Sartain
- Section of Hematology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
| | - Clifford M Takemoto
- Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
| | - Cristina Tarango
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
| | - C Heleen van Ommen
- Department of Pediatric Hematology, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands
| | - Maria C Velez
- Department of Pediatrics, Louisiana State University Health Sciences Center/Children's Hospital New Orleans, New Orleans, LA
| | - Sara K Vesely
- Hudson College of Public Health, Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma City, OK
| | - John Wiernikowski
- Division of Hematology & Oncology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada
| | - Suzan Williams
- Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
| | - Hope P Wilson
- Division of Pediatric Hematology/Oncology, Department of Pediatrics, Children's of Alabama, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL
| | - Gary Woods
- Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA
| | - Ayesha Zia
- Division of Hematology-Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
| | - Reem A Mustafa
- Division of Nephrology, Department of Internal Medicine, Evidence-based Practice and Impact Center, The University of Kansas Health System, Kansas City, KS
| |
Collapse
|
2
|
Theofanopoulos A, Proklou A, Miliaraki M, Konstantinou I, Ntotsikas K, Moustakis N, Lazarioti S, Papadakis E, Kypraios G, Angelidis G, Vaki G, Kondili E, Tsitsipanis C. Post-Traumatic Cerebral Venous Sinus Thrombosis (PtCVST) Resulting in Increased Intracranial Pressure during Early Post-Traumatic Brain Injury Period: Case Report and Narrative Literature Review. Healthcare (Basel) 2024; 12:1743. [PMID: 39273767 PMCID: PMC11395700 DOI: 10.3390/healthcare12171743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2024] [Revised: 08/18/2024] [Accepted: 08/24/2024] [Indexed: 09/15/2024] Open
Abstract
Post-traumatic cerebral venous sinus thrombosis (ptCVST) often remains underdiagnosed due to the non-specific nature of clinical signs, commonly mimicking severe traumatic brain injury (TBI) manifestations. Early recognition of this rare and potentially life-threatening complication is crucial for the effective management of severe TBI patients in Intensive Care. The present study reports the case of a 66-year-old male who was transferred to the emergency department due to moderate TBI. Initial emergency brain computed tomography (CT) scans revealed certain traumatic lesions, not necessitating any urgent neurosurgical intervention. During his stay in an Intensive Care Unit (ICU), multiple transient episodes of intracranial pressure (ICP) values were managed conservatively, and through placement of an external ventricular drain. Following a series of CT scans, there was a continuous improvement of the initial traumatic hemorrhagic findings despite his worsening clinical condition. This paradox raised suspicion for ptCVST, and a brain CT venography (CTV) was carried out, which showed venous sinus thrombosis close to a concomitant skull fracture. Therapeutic anticoagulant treatment was administered. The patient was discharged with an excellent neurological status. To date, there are no clearly defined guidelines for medical and/or surgical management of patients presenting with ptCVST. Therapy is mainly based on intracranial hypertension control and the maintenance of normal cerebral perfusion pressure (CCP) in the ICU. The mismatch between clinical and imaging findings in patients with TBI and certain risk factors raises the suspicion of ptCVST.
Collapse
Affiliation(s)
- Athanasios Theofanopoulos
- Neurosurgery Department, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Athanasia Proklou
- Intensive Care Unit, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Marianna Miliaraki
- Pediatric Intensive Care Unit, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Ioannis Konstantinou
- Intensive Care Unit, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Konstantinos Ntotsikas
- Neurosurgery Department, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Nikolaos Moustakis
- Neurosurgery Department, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Sofia Lazarioti
- Neurosurgery Department, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Eleftherios Papadakis
- Intensive Care Unit, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - George Kypraios
- School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | | | - Georgia Vaki
- School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Eumorfia Kondili
- Intensive Care Unit, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| | - Christos Tsitsipanis
- Neurosurgery Department, University Hospital of Heraklion, School of Medicine, University of Crete, 71003 Heraklion, Crete, Greece
| |
Collapse
|
3
|
Pais-Cunha I, Almeida AI, Curval AR, Fonseca J, Melo C, Sampaio M, Sousa R. Cerebral Venous Thrombosis in Pediatric Age: Risk Factors and Prognosis. Neuropediatrics 2024; 55:183-190. [PMID: 38057147 DOI: 10.1055/a-2223-6395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/08/2023]
Abstract
INTRODUCTION Cerebral venous thrombosis (CVT) is a rare but potentially fatal disease in pediatric age with an important morbimortality. In adults several factors have been associated with worse outcomes, however there are still few studies in children. This study aims to identify risk factors associated with clinical manifestations and long-term sequelae in pediatric CVT. METHODS Retrospective analysis of pediatric inpatients admitted to a tertiary-care hospital due to CVT between 2008 and 2020. RESULTS Fifty-four children were included, 56% male, median age of 6.5 years (9 months-17.3 years). Permanent risk factors were identified in 13 patients (malignancy, 8; hematologic condition, 5) and transient risk factors in 47, including head and neck infections (57%) and head trauma (15%). Multiple venous sinuses involvement was present in 65% and the deep venous system was affected in four patients. Seventeen percent had intracranial hemorrhage and 9% cerebral infarction. Sixty-four percent of patients with multiple venous sinuses involvement presented with severe clinical manifestations: impaired consciousness, intracranial hypertension, acute symptomatic seizures or focal deficits. Regarding long-term prognosis, six patients had major sequelae: epilepsy (n = 3), sensory motor deficits (n = 2), and cognitive impairment (n = 3). Permanent risk factors were associated with severe clinical manifestations (p = 0.043). Cerebral infarction and intracranial hemorrhage were associated with major sequelae (p = 0.006 and p = 0.03, respectively, adjusted for age and sex). CONCLUSION Permanent risk factors, involvement of multiple venous sinuses, intracranial hemorrhage, and cerebral infarction, were related to worse prognosis. Detection and early management of risk factors may limit CVT extension and reduce its morbimortality.
Collapse
Affiliation(s)
- Inês Pais-Cunha
- Serviço de Pediatria, Unidade Autónoma Gestão da Mulher e da Criança, Centro Hospitalar Universitário de São João, Porto, Portugal
| | - Ana I Almeida
- Serviço de Neurorradiologia, Centro Hospitalar Universitário São João, Porto, Portugal
| | - Ana R Curval
- Serviço de Pediatria, Unidade Autónoma Gestão da Mulher e da Criança, Centro Hospitalar Universitário de São João, Porto, Portugal
| | - Jacinta Fonseca
- Unidade de Neuropediatria, Unidade Autónoma Gestão da Mulher e da Criança, Centro Hospitalar Universitário de São João, Porto, Portugal
- Departamento de Ginecologia-Obstetrícia e Pediatria, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
| | - Cláudia Melo
- Unidade de Neuropediatria, Unidade Autónoma Gestão da Mulher e da Criança, Centro Hospitalar Universitário de São João, Porto, Portugal
- Departamento de Ginecologia-Obstetrícia e Pediatria, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
| | - Mafalda Sampaio
- Unidade de Neuropediatria, Unidade Autónoma Gestão da Mulher e da Criança, Centro Hospitalar Universitário de São João, Porto, Portugal
- Departamento de Ginecologia-Obstetrícia e Pediatria, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
| | - Raquel Sousa
- Unidade de Neuropediatria, Unidade Autónoma Gestão da Mulher e da Criança, Centro Hospitalar Universitário de São João, Porto, Portugal
- Departamento de Ginecologia-Obstetrícia e Pediatria, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
| |
Collapse
|
4
|
Johansen PM, Ciavarra B, McCormack R, Kole M, Spiegel G, Fletcher SA. Superior Sagittal Sinus Thrombectomy in Pediatric Head Injury. Pediatr Neurosurg 2024; 59:94-101. [PMID: 38461817 DOI: 10.1159/000538184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Accepted: 02/25/2024] [Indexed: 03/12/2024]
Abstract
INTRODUCTION Injury and subsequent thrombosis of the cerebral venous sinuses may be caused by closed head injuries secondary to a variety of different mechanisms. Skull fractures can lacerate or otherwise disrupt adjacent dural sinuses. The sequelae of such injuries may include thrombosis and either partial or total occlusion of the sinus, ultimately resulting in significant venous congestion. Sagittal sinus injury is associated with a more serious outcome due to the obligatory flow into the sinus, especially posterior to the coronal suture. In such cases, venous infarction may be a severe and life-threatening complication of head injury. CASE PRESENTATION A 2-year-old female presented with a depressed skull fracture near the midline and a thrombus in the sagittal sinus. Anticoagulation, the standard treatment cerebral venous sinus thrombosis (CVST), was contraindicated due to intracranial hemorrhage, so immediate thrombectomy was performed with successful neurologic recovery at 9-month follow-up. To our knowledge, this case is the youngest patient documented to receive mechanical thrombectomy for superior sagittal sinus (SSS) thrombosis due to trauma. CONCLUSION Closed head injuries in pediatric patients may be associated with CVST, with resulting venous drainage compromise and profound neurologic sequelae. Unlike adult patients with spontaneous CVST in which anticoagulation are the standard of care, pediatric patients experiencing traumatic CVST may have contraindications to anticoagulants. If the patient has a contraindication to anticoagulation such as intracranial bleeding, endovascular mechanical thrombectomy may be an effective intervention when performed by an experienced neurointerventionalist.
Collapse
Affiliation(s)
| | - Bronson Ciavarra
- McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA
| | - Ryan McCormack
- Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA
| | - Matthew Kole
- Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA
| | - Gary Spiegel
- Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA
| | - Stephen Alan Fletcher
- Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA
| |
Collapse
|